Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Galizzi, M. Borsotto, J. Barhanin, M. Fosset, M. Lazdunski (1986)
Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.The Journal of biological chemistry, 261 3
D. Ragsdale, J. McPhee, T. Scheuer, W. Catterall (1994)
Molecular determinants of state-dependent block of Na+ channels by local anesthetics.Science, 265 5179
K. Lee, K. Lee, R. Tsien (1983)
Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cellsNature, 302
T. Kamp, M. Sanguinetti, Richard Miller (1989)
Voltage‐ and Use‐Dependent Modulation of Cardiac Calcium Channels by the Dihydropyridine (+)‐202‐791Circulation Research, 64
S. Kokubun, H. Reuter (1984)
Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells.Proceedings of the National Academy of Sciences of the United States of America, 81 15
Blaise Peterson, T. Tanada, W. Catterall (1996)
Molecular Determinants of High Affinity Dihydropyridine Binding in L-type Calcium Channels (*)The Journal of Biological Chemistry, 271
H. Ishibashi, A. Yatani, N. Akaike (1995)
Block of P-type Ca2+ channels in freshly dissociated rat cerebellar Purkinje neurons by diltiazem and verapamilBrain Research, 695
R. Zobrist, T. Mecca (1990)
[3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization.The Journal of pharmacology and experimental therapeutics, 253 2
C. Cohen, R. McCarthy (1987)
Nimodipine block of calcium channels in rat anterior pituitary cells.The Journal of Physiology, 387
Joerg Mitterdorfer, M. Sinnegger, M. Grabner, Joerg Striessnig, H. Glossmann (1995)
Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit.Biochemistry, 34 29
S. Hering, T. Bolton, D. Beech, S. Lim (1989)
Mechanism of Calcium Channel Block by D600 in Single Smooth Muscle Cells From Rabbit Ear ArteryCirculation Research, 64
Masami Takahashi, M. Seagar, Jean Jones, B. Reber, W. Catterall (1987)
Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle.Proceedings of the National Academy of Sciences of the United States of America, 84 15
A. Uehara, J. Hume (1985)
Interactions of organic calcium channel antagonists with calcium channels in single frog atrial cellsThe Journal of General Physiology, 85
R. Kass, J. Arena (1989)
Influence of pHo on calcium channel block by amlodipine, a charged dihydropyridine compound. Implications for location of the dihydropyridine receptorThe Journal of General Physiology, 93
S. Regulla, T. Schneider, W. Nastainczyk, H. Meyer, F. Hofmann (1991)
Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium‐channel alpha 1 subunit.The EMBO Journal, 10
(1982)
Evidence of multiple receptor sites within the putative calcium channel. Naunyn-Schmiede
S. Heinemann, H. Terlau, W. Stühmer, K. Imoto, S. Numa (1992)
Calcium channel characteristics conferred on the sodium channel by single mutationsNature, 356
A. Karlin, M. Akabas (1995)
Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousinsNeuron, 15
C. Strübing, S. Hering, H. Glossmann (1993)
Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channelsBritish Journal of Pharmacology, 108
(1997)
SDA February
D. Ferry, M. Rombusch, A. Goll, H. Glossmann (1984)
Photoaffinity labelling of Ca2+ channels with [3H]azidopineFEBS Letters, 169
E. Kantrowitz, W. Lipscomb (1990)
Escherichia coli aspartate transcarbamoylase: the molecular basis for a concerted allosteric transition.Trends in biochemical sciences, 15 2
H. Kalasz, Toshiro Watanabe, H. Yabana, K. Itagaki, K. Naito, H. Nakayama, A. Schwartz, P. Vaghy (1993)
Identification of 1,4‐dihydropyridine binding domains within the primary structure of the α1 subunit of the skeletal muscle L‐type calcium channelFEBS Letters, 331
J. Striessnig, F. Scheffauer, J. Mitterdorfer, M. Schirmer, H. Glossmann (1990)
Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies.The Journal of biological chemistry, 265 1
M. Sieber, W. Nastainczyk, V. Žúbor, W. Wernet, F. Hofmann (1987)
The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel.European journal of biochemistry, 167 1
D. Triggle (1991)
Calcium‐Channel Drugs: Structure‐Function Relationships and Selectivity of ActionJournal of Cardiovascular Pharmacology, 18
W. Almers, E. McCleskey, P. Palade (1984)
A non‐selective cation conductance in frog muscle membrane blocked by micromolar external calcium ions.The Journal of Physiology, 353
A. Welling, E. Bosse, A. Cavalié, R. Bottlender, Andreas Ludwig, W. Nastainczyk, V. Flockerzi, Franz Hofmann (1993)
Stable co‐expression of calcium channel alpha 1, beta and alpha 2/delta subunits in a somatic cell line.The Journal of Physiology, 471
Mark Williams, D. Feldman, Ann McCue, R. Brenner, G. Velicelebi, S. Ellis, M. Harpold (1992)
Structure and functional expression of α 1, α 2, and β subunits of a novel human neuronal calcium channel subtypeNeuron, 8
A. Hui, P. Ellinor, O. Krizanova, Jing-ding Wang, R. Diebold, A. Schwartz (1991)
Molecular cloning of multiple subtypes of a novel rat brain isoform of the α 1 subunit of the voltage-dependent calcium channelNeuron, 7
(1987)
Calciumagonists . J. Mol. Cell. Cardiol
D. Rampe, B. Wible, A. Brown, R. Dage (1993)
Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart.Molecular pharmacology, 44 6
T. Marks, S. Jones (1992)
Calcium currents in the A7r5 smooth muscle-derived cell line. An allosteric model for calcium channel activation and dihydropyridine agonist actionThe Journal of General Physiology, 99
Susumu Seino, Ling Chen, Mitsuko Seino, Olivier Blondel, Jun Takeda, John Johnson, Graeme Bell (1992)
Cloning of the alpha 1 subunit of a voltage-dependent calcium channel expressed in pancreatic beta cells.Proceedings of the National Academy of Sciences of the United States of America, 89 2
Y. Mori, T. Friedrich, Man-Suk Kim, A. Mikami, J. Nakai, P. Ruth, E. Bosse, F. Hofmann, V. Flockerzi, T. Furuichi, K. Mikoshiba, K. Imoto, T. Tanabe, S. Numa (1991)
Primary structure and functional expression from complementary DNA of a brain calcium channelNature, 350
S. Kokubun, B. Prod'hom, C. Becker, H. Porzig, H. Reuter (1986)
Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.Molecular pharmacology, 30 6
W. Catterall, J. Striessnig (1992)
Receptor sites for Ca2+ channel antagonists.Trends in pharmacological sciences, 13 6
W. Sather, Jian Yand, R. Tsien (1994)
Structural basis of ion channel permeation and selectivityCurrent Opinion in Neurobiology, 4
B. Bean (1984)
Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state.Proceedings of the National Academy of Sciences of the United States of America, 81 20
J. Striessnig, B. Murphy, W. Catterall (1991)
Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.Proceedings of the National Academy of Sciences of the United States of America, 88 23
P. Hess, J. Lansman, R. Tsien (1984)
Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonistsNature, 311
N. Leblanc, J. Hume (1989)
D 600 block of L-type Ca2+ channel in vascular smooth muscle cells: comparison with permanently charged derivative, D 890.The American journal of physiology, 257 4 Pt 1
G. Hockerman, Barry Johnson, Michael Abbott, T. Scheuer, W. Catterall (1997)
Molecular Determinants of High Affinity Phenylalkylamine Block of l-type Calcium Channels in Transmembrane Segment IIIS6 and the Pore Region of the α1Subunit*The Journal of Biological Chemistry, 272
T. Tanabe, H. Takeshima, A. Mikami, V. Flockerzi, Hideo Takahashi, K. Kangawa, M. Kojima, H. Matsuo, T. Hirose, S. Numa (1987)
Primary structure of the receptor for calcium channel blockers from skeletal muscleNature, 328
A. Depover, M. Matlib, S. Lee, G. Dubé, I. Grupp, G. Grupp, A. Schwartz (1982)
Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem.Biochemical and biophysical research communications, 108 1
A. Gurney, J. Nerbonne, H. Lester (1985)
Photoinduced removal of nifedipine reveals mechanisms of calcium antagonist action on single heart cellsThe Journal of General Physiology, 86
R. Kass, J. Arena, S. Chin (1991)
Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calciumThe Journal of General Physiology, 98
I. Reynolds, A. Snowman, S. Snyder (1986)
(-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.The Journal of pharmacology and experimental therapeutics, 237 3
Shaoqing Tang, Atsuko Yatan, A. Bahinski, Y. Mori, A. Schwartz (1993)
Molecular localization of regions in the L-type calcium channel critical for dihydropyridine actionNeuron, 11
M. Sanguinetti, R. Kass (1984)
Voltage‐Dependent Block of Calcium Channel Current in the Calf Cardiac Purkinje Fiber by Dihydropyridine Calcium Channel AntagonistsCirculation Research, 55
T. Suzuki, H. Kurosawa, K. Naito, M. Otsuka, M. Ohashi, O. Takaiti (1991)
Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes.European journal of pharmacology, 194 2-3
L. Isom, K. Jongh, W. Catterall (1994)
Auxiliary subunits of voltage-gated ion channelsNeuron, 12
R. Gould, K. Murphy, S. Snyder (1983)
Studies on voltage-operated calcium channels using radioligands.Cold Spring Harbor symposia on quantitative biology, 48 Pt 1
T. Mcdonald, S. Pelzer, W. Trautwein, D. Pelzer (1994)
Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells.Physiological reviews, 74 2
M. Sanguinetti, D. Krafte, R. Kass (1986)
Voltage-dependent modulation of Ca channel current in heart cells by Bay K8644The Journal of General Physiology, 88
T. Mcdonald, D. Pelzer, W. Trautwein (1984)
Cat ventricular muscle treated with D600: characteristics of calcium channel block and unblock.The Journal of Physiology, 352
B. Johnson, G. Hockerman, T. Scheuer, W. Catterall (1996)
Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines.Molecular pharmacology, 50 5
H. Nakayama, M. Taki, J. Striessnig, H. Glossmann, W. Catterall, Y. Kanaoka (1991)
Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.Proceedings of the National Academy of Sciences of the United States of America, 88
S. Hamilton, A. Yatani, K. Brush, A. Schwartz, A. Brown (1987)
A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.Molecular pharmacology, 31 3
S. Kanaya, P. Arlock, B. Katzung, L. Hondeghem (1983)
Diltiazem and verapamil preferentially block inactivated cardiac calcium channels.Journal of molecular and cellular cardiology, 15 2
R. Boles, H. Yamamura, H. Schoemaker, W. Roeske (1984)
Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.The Journal of pharmacology and experimental therapeutics, 229 2
H. Glossmann, D. Ferry, A. Goll, M. Rombusch (1984)
Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.Journal of cardiovascular pharmacology, 6 Suppl 4
B. Curtis, W. Catterall (1984)
Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules.Biochemistry, 23 10
Judith Williams, I. Grupp, Gunter Grupp, P. Vaghy, Louis Dumont, Arnold Schwartz, Atsuko Yatani, Susan Hamilton, Arthur Brown (1985)
Profile of the oppositely acting enantiomers of the dihydropyridine 202-791 in cardiac preparations: receptor binding, electrophysiological, and pharmacological studies.Biochemical and biophysical research communications, 131 1
J. Baulida, M. Kraus, M. Alimandi, P. Fiore, G. Carpenter (1996)
All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired (*)The Journal of Biological Chemistry, 271
Arthur Brown, Diana Kunze, Atsuko Yatani (1986)
Dual effects of dihydropyridines on whole cell and unitary calcium currents in single ventricular cells of guinea‐pig.The Journal of Physiology, 379
P. Hess, R. Tsien (1984)
Mechanism of ion permeation through calcium channelsNature, 309
S. Hering, S. Aczél, M. Grabner, F. Döring, S. Berjukow, J. Mitterdorfer, M. Sinnegger, J. Striessnig, V. Degtiar, Zhengyi Wang, H. Glossmann (1996)
Transfer of High Sensitivity for Benzothiazepines from L-type to Class A (BI) Calcium Channels*The Journal of Biological Chemistry, 271
K. Dunlap, J. Luebke, T. Turner (1995)
Exocytotic Ca2+ channels in mammalian central neuronsTrends in Neurosciences, 18
Shaoqing TangS, Gabor MikalaSEi, Anthony BahinskiS, Atsuko Yatani, Gyula Varadil, Arnold Schwartzli (1993)
Molecular localization of ion selectivity sites within the pore of a human L-type cardiac calcium channel.The Journal of biological chemistry, 268 18
T. Snutch, W. Tomlinson, J. Leonard, M. Gilbert (1991)
Distinct calcium channels are generated by alternative splicing and are differentially expressed in the mammalian CNSNeuron, 7
M. Grabner, Zhengyi Wang, S. Hering, J. Striessnig, H. Glossmann (1996)
Transfer of 1,4-Dihydropyridine Sensitivity from L-Type to Class A (BI) Calcium ChannelsNeuron, 16
S. Herzig, H. Lüllmann, H. Sieg (1992)
Frequency- and potential-dependency of the negative inotropic action of various dihydropyridine and non-dihydropyridine calcium antagonists.Pharmacology & toxicology, 71 3 Pt 1
D. Barford, L. Johnson (1989)
The allosteric transition of glycogen phosphorylaseNature, 340
(1996)
Identification of benz(othi)azepine-binding regions P1: SDA/RSK P2: SDA/PLB QC: SDA February 11
T. Starr, W. Prystay, T. Snutch (1991)
Primary structure of a calcium channel that is highly expressed in the rat cerebellum.Proceedings of the National Academy of Sciences of the United States of America, 88
A. Schuster, Ľ. Lacinová, N. Klugbauer, H. Ito, L. Birnbaumer, F. Hofmann (1996)
The IVS6 segment of the L‐type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.The EMBO Journal, 15
R. Janis, D. Rampe, J. Sarmiento, D. Triggle (1984)
Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain.Biochemical and biophysical research communications, 121 1
B. Hille (1977)
Local anesthetics: hydrophilic and hydrophobic pathways for the drug- receptor reactionThe Journal of General Physiology, 69
S. Kimball, J. Hunt, J. Barrish, J. Das, D. Floyd, M. Lago, V. Lee, S. Spergel, S. Moreland, S. Hedberg (1993)
1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil.Bioorganic & medicinal chemistry, 1 4
A. Lacerda, A. Brown (1989)
Nonmodal gating of cardiac calcium channels as revealed by dihydropyridinesThe Journal of General Physiology, 93
R. Kass (1987)
Voltage‐Dependent Modulation of Cardiac Calcium Channel Current by Optical Isomers of Bay K 8644: Implications for Channel GatingCirculation Research, 61
L. Rakotoarisoa, I. Sayet, C. Mironneau, J. Mironneau (1990)
Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.The Journal of pharmacology and experimental therapeutics, 255 3
S. Kimball, D. Floyd, J. Das, J. Hunt, J. Krapcho, G. Rovnyak, K. Duff, V. Lee, R. Moquin, C. Turk (1992)
Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.Journal of medicinal chemistry, 35 4
M. Blaber, Xuejun Zhang, B. Matthews (1993)
Structural basis of amino acid alpha helix propensity.Science, 260 5114
F. Döring, V. Degtiar, M. Grabner, J. Striessnig, S. Hering, H. Glossmann (1996)
Transfer of L-type Calcium Channel IVS6 Segment Increases Phenylalkylamine Sensitivity of (*)The Journal of Biological Chemistry, 271
Blaise Peterson, W. Catterall (1995)
Calcium Binding in the Pore of L-type Calcium Channels Modulates High Affinity Dihydropyridine Binding (*)The Journal of Biological Chemistry, 270
T. Yamagishi, K. Ishii, N. Taira (1995)
Antiarrhythmic and bradycardic drugs inhibit currents of cloned K+ channels, KV1.2 and KV1.4.European journal of pharmacology, 281 2
A. Sharp, T. Imagawa, A. Leung, K. Campbell (1987)
Identification and characterization of the dihydropyridine-binding subunit of the skeletal muscle dihydropyridine receptor.The Journal of biological chemistry, 262 25
T. Niidome, Man-Suk Kim, T. Friedrich, Y. Mori (1992)
Molecular cloning and characterization of a novel calcium channel from rabbit brainFEBS Letters, 308
H. Glossmann, D. Ferry, A. Goll, J. Striessnig, G. Zernig (1985)
Calcium channels and calcium channel drugs: recent biochemical and biophysical findings.Arzneimittel-Forschung, 35 12A
Yiping Zhang, J. Liang, Shenghua Huang, W. Lipscomb (1994)
Toward a mechanism for the allosteric transition of pig kidney fructose-1,6-bisphosphatase.Journal of molecular biology, 244 5
Jian Yang, Patrick Elllnor, W. Sather, Ji-fang Zhang, R. Tsien (1993)
Molecular determinants of Ca2+ selectivity and ion permeation in L-type Ca2+ channelsNature, 366
F. Hofmann, M. Biel, V. Flockerzi (1994)
Molecular basis for Ca2+ channel diversity.Annual review of neuroscience, 17
T. Mcdonald, D. Pelzer, W. Trautwein (1984)
Cat ventricular muscle treated with D600: effects on calcium and potassium currents.The Journal of Physiology, 352
Jonas Galper, William Catterall (1979)
Inhibition of sodium channels by D600.Molecular pharmacology, 15 1
R. Bangalore, N. Baindur, A. Rutledge, D. Triggle, R. Kass (1994)
L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.Molecular pharmacology, 46 4
W. Catterall (1993)
Structure and function of voltage-gated ion channelsTrends in Neurosciences, 16
K. Naito, E. McKenna, A. Schwartz, P. Vaghy (1989)
Photoaffinity labeling of the purified skeletal muscle calcium antagonist receptor by a novel benzothiazepine, [3H]azidobutyryl diltiazem.The Journal of biological chemistry, 264 35
M. dHosey, Jacques Barhanin, Annie Schmid, S. Vandaele, Judy Ptasienski, C. O’Callahan, Christy Cooper, M. Lazdunski (1987)
Photoaffinity labelling and phosphorylation of a 165 kilodalton peptide associated with dihydropyridine and phenylalkylamine-sensitive calcium channels.Biochemical and biophysical research communications, 147 3
P. Vaghy, J. Striessnig, K. Miwa, H. Knaus, K. Itagaki, E. McKenna, H. Glossmann, A. Schwartz (1987)
Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations.The Journal of biological chemistry, 262 29
J. Striessnig, H. Glossmann, W. Catterall (1990)
Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.Proceedings of the National Academy of Sciences of the United States of America, 87
N. Soldatov, A. Bouron, H. Reuter (1995)
Different Voltage-dependent Inhibition by Dihydropyridines of Human Ca Channel Splice Variants (*)The Journal of Biological Chemistry, 270
S. Hering, A. Savchenko, C. Strübing, M. Lakitsch, J. Striessnig (1993)
Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels.Molecular pharmacology, 43 5
D. Floyd, S. Kimball, J. Krapcho, J. Das, C. Turk, R. Moquin, M. Lago, K. Duff, V. Lee, R. White (1992)
Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones.Journal of medicinal chemistry, 35 4
T. Nagao, M. Sato, H. Nakajima, A. Kiyomoto (1973)
Studies on a new 1,5-benzothiazepine derivative (CRD-401). IV. Coronary vasodilating effect and structure-activity relationship.Chemical & pharmaceutical bulletin, 21 1
J. Galizzi, M. Fosset, M. Lazdunski (1985)
Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.Biochemical and biophysical research communications, 132 1
W. Koch, P. Ellinor, A. Schwartz (1990)
cDNA cloning of a dihydropyridine-sensitive calcium channel from rat aorta. Evidence for the existence of alternatively spliced forms.The Journal of biological chemistry, 265 29
H. Glossmann, D. Ferry, A. Goll (1984)
Molecular pharmacology of the calcium channel
G. Hockerman, Barry Johnson, T. Scheuer, W. Catterall (1995)
Molecular Determinants of High Affinity Phenylalkylamine Block of L-type Calcium Channels (*)The Journal of Biological Chemistry, 270
L. Birnbaumer, K. Campbell, W. Catterall, M. Harpold, F. Hofmann, W. Horne, Y. Mori, A. Schwartz, T. Snutch, T. Tanabe, R. Tsien (1994)
The naming of voltage-gated calcium channelsNeuron, 13
L. Herbette, Y. Erve, David Rhodes (1989)
Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors.Journal of molecular and cellular cardiology, 21 2
David Ragsdale, T. Scheuer, W. Catterall (1991)
Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.Molecular pharmacology, 40 5
Toshiro Watanabe, H. Kalasz, H. Yabana, A. Kuniyasu, J. Mershon, K. Itagaki, P. Vaghy, K. Naito, H. Nakayama, A. Schwartz (1993)
Azidobutyryl clentiazem, a new photoactivatable diltiazem analog, labels benzothiazepine binding sites in the α1 subunit of the skeletal muscle calcium channelFEBS Letters, 334
W. Catterall (1995)
Structure and function of voltage-gated ion channels.Annual review of biochemistry, 64
K. Lee, R. Tsien (1984)
High selectivity of calcium channels in single dialysed heart cells of the guinea‐pig.The Journal of Physiology, 354
A. Mikami, K. Imoto, T. Tanabe, T. Niidome, Y. Mori, H. Takeshima, S. Narumiya, S. Numa (1989)
Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channelNature, 340
J. Striessnig, H. Knaus, M. Grabner, K. Moosburger, W. Seitz, H. Lietz, H. Glossmann (1987)
Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse‐tubule calcium channelFEBS Letters, 212
A. Rutledge, D. Triggle (1995)
The binding interactions of Ro 40-5967 at the L-type Ca2+ channel in cardiac tissue.European journal of pharmacology, 280 2
L. Hondeghem, B. Katzung (1984)
Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs.Annual review of pharmacology and toxicology, 24
▪ Abstract The crucial role of L-type Ca 2+ channels in the initiation of cardiac and smooth muscle contraction has made them major therapeutic targets for the treatment of cardiovascular disease. L-type channels share a common pharmacological profile, including high-affinity voltage- and frequency-dependent block by the phenylalkylamines, the benz(othi)azepines, and the dihydropyridines. These drugs are thought to bind to three separate receptor sites on L-type Ca 2+ channels that are allosterically linked. Results from different experimental approaches implicate the IIIS5, IIIS6, and IVS6 transmembrane segments of the α 1 subunits of L-type Ca 2+ channels in binding of all three classes of drugs. Site-directed mutagenesis has identified single amino acid residues within the IIIS5, IIIS6, and IVS6 transmembrane segments that are required for high-affinity binding of phenylalkylamines and/or dihydropyridines, providing further support for identification of these transmembrane segments as critical elements of the receptor sites for these two classes of drugs. The close proximity of the receptor sites for phenylalkylamines, benz(othi)azepines, and dihydropyridines raises the possibility that individual amino acid residues may be required for high-affinity binding of more than one of these ligands. Therefore, we suggest that phenylalkylamines and dihydropyridines bind to different faces of the IIIS6 and IVS6 transmembrane segments and, in some cases, bind to opposite sides of the side chains of the same amino acid residues. The results support the domain interface model for binding and channel modulation by these three classes of drugs.
Annual Review of Pharmacology and Toxicology – Annual Reviews
Published: Apr 1, 1997
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.